Secondly, LLL12 reduced tumor-associated angiogenic factors (VEGF, MMP-9, angiopoetin, TF and FGF1), probably as a direct consequence of STAT3 inhibition in tumor cells. This evidence concerns the gene STAT3 and neoplasm.